potentiator

(redirected from Potentiators)
Also found in: Dictionary, Encyclopedia.

po·ten·ti·a·tor

(pō-ten'shē-ā-tŏr, -tōr),
In chemotherapy, a drug used in combination with other drugs to produce deliberate potentiation.
Any factor that amplifies another factor—e.g., stress, chronic illness, etc.—and lowers the threshold for suicide completion
References in periodicals archive ?
The Potentiator program works by disrupting the outer cell membrane of gram-negative bacteria, which is what presents a persistent barrier for many antibiotics.
One study, which compared the use of papain-treated RBCs to procedures involving LISS alone or LISS-papain combinations, found that the use of a potentiator in adsorption procedures decreased the mean processing time from 180 minutes to 57.
We'll look at recent advances on the flavor ingredient/flavor processing fronts, including bitter blockers (techniques allowing for soy and vitamin enriched foods to be more palatable), fat mimetics, sweetness potentiators and masking non-nutritive sweeteners.
Linguagen develops ingredients used to improve the taste of food, beverages and pharmaceutical products, such as bitter blockers and sweetness potentiators.
Synergists as potentiators to juvenile hormone analogues in susceptible and fenitrothion-resistant strains of the cotton leafworm Spodoptera littoralis (Boisd).
In addition, Proteostasis Therapeutics scientists will present preclinical data on its planned triple combination therapy, as well as a new class of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators with characteristics distinct from known potentiators, correctors and amplifiers.
Sharon Laboratories, for instance, has blends with caprylyl glycol and 1,2-hexylenediol, which are emollients and humectants that are also potentiators or boosters that increase the efficacy of the preservative blend, according to Sathre.
SeeNews) - Oct 17, 2013 -A Belgian biotechnology firm Galapagos (EBR:GLPG) said today it had developedA a series of novel potentiators in its cystic fibrosis programme, with the data to be presented at theA North American Cystic Fibrosis Conference.
Thus, more effective 5-FU dosages and the development of 5-FU specific potentiators are indispensable for improving the quality of life of cancer patients.
Meehl proposed a model of the cause and pathogenesis of schizophrenia and related states, where polygenic potentiators play an important role in this developmental process, interacting with biopsychosocial factors (Meehl, 1990).